PMGC Holdings (ELAB) Research & Development (2022 - 2026)
PMGC Holdings (ELAB) reported Research & Development of $310,219 for Q2 2026, up 365.3% from $66,675 a year earlier and up 559.2% from the prior quarter.
Powered by 
Analysis
PMGC Holdings (ELAB) Research & Development (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, PMGC Holdings' Research & Development came in at $405,182, up 173.4% year-over-year; for FY2025, it came in at $147,010, up 40.5% from FY2024.
- Research & Development has a three-year compound annual growth rate of -13.7% (FY2022 to FY2025).
- By year, Research & Development came in at $104,654 in FY2024, $7,410 in FY2023 (-96.8%) and $228,747 in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Research & Development since Q3 2022.
- Year over year, Research & Development gained in four of the last six quarters, with growth averaging 107.6%.
- The high point for year-over-year Research & Development in five years was Q2 2026 (growth of 365.3%); the low point was Q3 2023 (a decline of 99.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $47,061 (Q1 2026), $32,902 (Q4 2025) and $15,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | PMGC Holdings | 1.73 Mn | -46.63 Mn | 385,691.00 | 310,219.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 310,219.00 |
| Mar 31, 2026 | 47,061.00 |
| Dec 31, 2025 | 32,902.00 |
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 66,675.00 |
| Mar 31, 2025 | 32,433.00 |
| Dec 31, 2024 | 45,003.00 |
| Sep 30, 2024 | 4,098.00 |
| Jun 30, 2024 | 34,824.00 |
| Mar 31, 2024 | 2,782.00 |
| Dec 31, 2023 | -296,359.00 |
| Sep 30, 2023 | 86,374.00 |
| Jun 30, 2023 | 133,654.00 |
| Mar 31, 2023 | 83,741.00 |
| Dec 31, 2022 | -167.66 Mn |
| Sep 30, 2022 | 89.33 Mn |
API Access
PMGC Holdings Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ELAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ELAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ELAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();